26 research outputs found

    Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Amongst the extensive literature on immunohistochemical profile of breast cancer, very little is found on populations exposed to a potential risk factor such as depleted uranium. This study looked at the immunohistochemical expression of HER-2/neu (c-erbB2) and p53 in different histological types of breast cancer found in the middle Euphrates region of Iraq, where the population has been exposed to high levels of depleted uranium.</p> <p>Findings</p> <p>The present investigation was performed over a period starting from September 2008 to April 2009. Formalin-fixed, paraffin-embedded blocks from 70 patients with breast cancer (62 ductal and 8 lobular carcinoma) were included in this study. A group of 25 patients with fibroadenoma was included as a comparative group, and 20 samples of normal breast tissue sections were used as controls. Labeled streptavidin-biotin (LSAB+) complex method was employed for immunohistochemical detection of HER-2/neu and p53.</p> <p>The detection rate of HER-2/neu and p53 immunohistochemical expression were 47.14% and 35.71% respectively in malignant tumors; expression was negative in the comparative and control groups (p < 0.05).</p> <p>HER-2/neu immunostaining was significantly associated with histological type, tumor size, nodal involvement, and recurrence of breast carcinoma (<it>p </it>< 0.05), p53 immunostaining was significantly associated with tumor size, nodal involvement and recurrence of breast cancer (<it>p </it>< 0.05). There was greater immunoexpression of HER-2/neu in breast cancer in this population, compared with findings in other populations.</p> <p>Both biomarkers were positively correlated with each other. Furthermore, all the cases that co-expressed both HER-2/neu and p53 showed the most unfavorable biopathological profile.</p> <p>Conclusion</p> <p>P53 and HER-2/neu over-expression play an important role in pathogenesis of breast carcinoma. The findings indicate that in regions exposed to high levels of depleted uranium, although p53 and HER-2/neu overexpression are both high, correlation of their expression with age, grade, tumor size, recurrence and lymph node involvement is similar to studies that have been conducted on populations not exposed to depleted uranium. HER-2/neu expression in breast cancer was higher in this population, compared with results on non-exposed populations.</p

    Ecologically Sustainable Exploitation Rates—A multispecies approach for fisheries management

    No full text
    Fisheries management is slowly evolving from its traditional single-species focus to a more holistic ecosystem-based approach. Yet, limits for exploitation are almost always set based on single-species models, treating species as isolated entities. This is problematic since the sustainability of a fishery hinges on its effects on the exploited community as a whole. Here, we develop a novel analytical approach of estimating exploitation rates that are sustainable with respect to the state of whole fish communities. Our approach simultaneously addresses species interactions, environmental covariates and natural variability of population sizes, yet it is framed around a simple and accessible objective. We derive Ecologically Sustainable Exploitation Rates, that is exploitation rates associated with a maximum acceptable probability (determined by management) that any interacting species decreases to an unacceptably low population size. Using models fitted to an exploited fish community, we show how accounting for species interactions constrains the possibilities for ecologically sustainable exploitation. The conventional omission of species interactions may thus result in overestimated exploitation limits. Moreover, our application rendered a counterintuitive result: it suggests that the exploitation of one species should increase, as compared to mean historical levels, for the purpose of conservation of the community as a whole. Such insights could impossibly be gained using single-species approaches, illustrating the need to adopt multispecies models in fisheries management. Analytical derivation of Ecologically Sustainable Exploitation Rates offers a mean to do so

    Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer

    No full text
    Introduction and objectives Bladder cancer is primarily a disease of older age and little is known about the differences between patients diagnosed with bladder cancer at a younger versus older age. Our objectives were to compare bladder cancer specific survival in patients aged &lt;50 versus those aged 50–70 at time of diagnosis. Materials and methods The Swedish bladder cancer database provided data on patient demographics, clinical characteristics and treatments for this observational study. Cox proportional hazard regression models were adjusted for appropriate variables. All analyses were stratified by disease stage (non-muscle-invasive bladder cancer and muscle-invasive bladder cancer. Furthermore, we compared the frequency of lower urinary tract infections within 24 months prior to bladder cancer diagnosis by sex and age groups. Results The study included 15,452 newly-diagnosed BC patients (1997-2014); 1,207 (8%) patients were &lt;50 whilst 14,245 (92%) were aged 50-70. Patients aged &lt;50 at diagnosis were at a decreased risk of bladder cancer death (HR = 0.82, 95%CI: 0.68-0.99) compared to those aged 50-70. When stratified by non-muscle-invasive and muscle-invasive bladder cancer, this association remained in non-muscle-invasive patients only (&lt;50, HR = 0.43, 95% CI: 0.28-0.64). The frequency of lower urinary tract infection diagnoses did not differ between younger and older patients in either men or women. Conclusions Patients diagnosed with non-muscle-invasive bladder cancer when aged &lt;50 are at decreased risk of bladder cancer-specific death when compared to their older (50-70) counterparts. These observations raise relevant research questions about age-related differences in diagnostic procedures, clinical decision-making and, not least, potential differences in tumour biology
    corecore